Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:04 AM
Ignite Modification Date:
2025-12-25 @ 5:04 AM
NCT ID:
NCT00201318
Eligibility Criteria:
* Inclusion Criteria:
1. Histologically proven NHL, and for which intensive chemotherapy is considered treatment-of-choice.
2. HBsAg-positive.
3. No previous chemotherapy and radiotherapy, no concurrent radiotherapy.
4. AGC ≧ 2,000/mm3, Platelet ≧ 100,000/mm3 of peripheral blood.
5. Total bilirubin \< 2.5 mg/dl. Alanine aminotransferase (SGPT) \< 200 I.U./L
6. Serum creatinine ≦1.5 mg/dl Blood urea nitrogen (BUN) ≦ 25 mg/dl
7. Objectively measurable or valuable disease
8. Signed informed consent
* Exclusion Criteria:
1. Age \> 75 years old, or Age \< 15 years old
2. Pregnant or breast-feeding women.
3. Patients with history of brain metastasis or CNS involvement.
4. Child's class B or C in patients with liver cirrhosis.
5. Impaired cardiac function with NYHA (New York Heart Association) classification ≧ Gr II.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
70 Years
Study:
NCT00201318
Study Brief:
Protocol Section:
NCT00201318